Narula Sanjeev bought PHAT
January 2, 2026 · Form 4 insider transaction
Narula Sanjeev bought 42,848 shares of Phathom Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
42,848
Price
$0.00
Total value
N/A
InsiderNarula Sanjeev
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 2, 2026
Filing dateJanuary 2, 2026
Shares owned after42,848
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
1/48th of the total number of shares of common stock subject to the option vest monthly following the Vesting Commencement Date, subject to the Reporting Person's continuous service to the Issuer through each vesting date.